Ardent Health holders offer 8M shares at $14.50
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Ardent Health, Inc. (ARDT) common stock is the subject of a resale in which selling stockholders are offering 8,000,000 shares, with an underwriters’ option for up to 1,200,000 additional shares. The public offering price is $14.50 per share, and Ardent will not receive proceeds from the selling stockholders’ sales. Subject to completion of the offering, Ardent intends to repurchase 1,500,000 of the offered shares from the underwriters at the price they pay the selling stockholders, then cancel them. Ardent intends to fund the repurchase with cash on hand; the offering is not conditioned on the repurchase.
Ardent entered into a definitive agreement to acquire Boone Health for $47 million, with closing expected in the first quarter of 2027, subject to customary closing conditions. After the offering and repurchase, EGI-AM is expected to beneficially own 70,109,780 shares and approximately 50.3% of voting power (approximately 49.5% if the underwriters exercise their option in full).
Filing Explained
Full exercise of the underwriters’ option would put EGI-AM below the fifty-percent voting-power condition for its stated majority-director nomination right.
Delivery of the selling stockholders’ resale is expected on or about
EGI-AM’s right to nominate a majority of directors is subject to its holding at least
Key Figures
Key Terms
Concurrent Share Repurchase financial
controlled company regulatory
underwriting discounts and commissions financial
beneficial owner regulatory
Restricted Period regulatory
Rule 144 regulatory
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ARDT shares are being offered?
What are the terms of the ARDT underwriters’ option?
How many shares does Ardent Health intend to repurchase?
What does the Boone Health acquisition include?
Will EGI-AM retain voting control of ARDT after the offering?
AI-generated analysis. How Rhea-AI works. Not financial advice.
To Prospectus dated August 25, 2025
| | | |
Per share
|
| |
Total
|
| ||||||
| Public offering price(1) | | | | $ | 14.50 | | | | | $ | 94,250,000.00 | | |
| Underwriting discounts and commissions(2) | | | | $ | 0.7975 | | | | | $ | 5,183,750.00 | | |
| Proceeds, before expenses, to the selling stockholders(3) | | | | $ | 13.7025 | | | | | $ | 109,620,000.00 | | |
| | J.P. Morgan | | |
Barclays
|
| |||
| |
BofA Securities
|
| | Citigroup | | |
Leerink Partners
|
| |
Mizuho
|
|
| |
RBC Capital Markets
|
| |
Stephens Inc.
|
| |
Truist Securities
|
|
| | | | |
Capital One Securities
|
| | | |
| | | |
Page
|
| |||
|
ABOUT THIS PROSPECTUS SUPPLEMENT
|
| | | | S-iii | | |
|
CAUTIONARY LANGUAGE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | S-iv | | |
|
PROSPECTUS SUPPLEMENT SUMMARY
|
| | | | S-1 | | |
|
RISK FACTORS
|
| | | | S-5 | | |
| THE CONCURRENT SHARE REPURCHASE | | | | | S-9 | | |
|
USE OF PROCEEDS
|
| | | | S-10 | | |
|
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS
|
| | | | S-11 | | |
|
SELLING STOCKHOLDERS
|
| | | | S-14 | | |
| UNDERWRITING | | | | | S-15 | | |
|
LEGAL MATTERS
|
| | | | S-28 | | |
| EXPERTS | | | | | S-29 | | |
|
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | S-30 | | |
|
INCORPORATION BY REFERENCE
|
| | | | S-31 | | |
| | | |
Page
|
| |||
|
ABOUT THIS PROSPECTUS
|
| | | | ii | | |
| SUMMARY | | | | | 1 | | |
|
RISK FACTORS
|
| | | | 2 | | |
|
FORWARD-LOOKING STATEMENTS
|
| | | | 3 | | |
|
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | 5 | | |
|
INFORMATION INCORPORATED BY REFERENCE
|
| | | | 6 | | |
|
USE OF PROCEEDS
|
| | | | 7 | | |
|
GENERAL DESCRIPTION OF SECURITIES
|
| | | | 8 | | |
|
DESCRIPTION OF CAPITAL STOCK
|
| | | | 9 | | |
|
DESCRIPTION OF DEBT SECURITIES
|
| | | | 14 | | |
|
SELLING STOCKHOLDERS
|
| | | | 26 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 28 | | |
|
LEGAL MATTERS
|
| | | | 33 | | |
| EXPERTS | | | | | 33 | | |
| | | |
Shares of common stock
|
| |||||||||||||||||||||||||||||||||||||||||||||
|
Name of beneficial owner
|
| |
Beneficially
owned before the offering and the Concurrent Share Repurchase |
| |
Offered,
assuming underwriters’ option is not exercised |
| |
Beneficially
owned after the offering and the Concurrent Share Repurchase, assuming underwriters’ option is not exercised |
| |
Offered,
Assuming Underwriters’ Option is Exercised in Full |
| |
Beneficially
owned after the offering and the Concurrent Share Repurchase, assuming underwriters’ option is exercised in full |
| |||||||||||||||||||||||||||||||||
| |
Number
|
| |
%
|
| |
Number
|
| |
Number
|
| |
%
|
| |
Number
|
| |
Number
|
| |
%
|
| ||||||||||||||||||||||||||
|
EGI-AM Investments, L.L.C.(1)(3)
|
| | | | 77,246,499 | | | | | | 54.8% | | | | | | 7,136,719 | | | | | | 70,109,780 | | | | | | 50.3% | | | | | | 8,207,227 | | | | | | 69,039,272 | | | | | | 49.5% | | |
|
ALH Holdings, LLC(2)(3)
|
| | | | 9,342,501 | | | | | | 6.6% | | | | | | 863,281 | | | | | | 8,479,220 | | | | | | 6.1% | | | | | | 992,773 | | | | | | 8,349,728 | | | | | | 6.0% | | |
|
Underwriter
|
| |
Number of shares
|
| |||
|
J.P. Morgan Securities LLC
|
| | | | 2,800,000 | | |
|
Barclays Capital Inc.
|
| | | | 2,220,000 | | |
|
BofA Securities, Inc.
|
| | | | 420,000 | | |
|
Citigroup Global Markets Inc.
|
| | | | 420,000 | | |
|
Leerink Partners LLC
|
| | | | 420,000 | | |
|
Mizuho Securities USA LLC
|
| | | | 420,000 | | |
|
RBC Capital Markets, LLC
|
| | | | 420,000 | | |
|
Stephens Inc.
|
| | | | 420,000 | | |
|
Truist Securities, Inc.
|
| | | | 420,000 | | |
|
Capital One Securities, Inc.
|
| | | | 40,000 | | |
|
Total
|
| | | | 8,000,000 | | |
| | | | | | |
Total
|
| ||||||||||||
| | | |
Per share
|
| |
No exercise
|
| |
Full exercise
|
| |||||||||
|
Public offering price(1)
|
| | | $ | 14.50 | | | | | $ | 94,250,000.00 | | | | | $ | 111,650,000.00 | | |
|
Underwriting discounts and commissions borne by the selling stockholders(1)
|
| | | $ | 0.7975 | | | | | $ | 5,183,750.00 | | | | | $ | 6,140,750.00 | | |
| |
Section 96(1) (a)
|
| | the offer, transfer, sale, renunciation or delivery is to: | |
| | | | |
(i)
persons whose ordinary business, or part of whose ordinary business, is to deal in securities, as principal or agent;
|
|
| | | | |
(ii)
the South African Public Investment Corporation;
|
|
| | | | |
(iii)
persons or entities regulated by the Reserve Bank of South Africa;
|
|
| | | | |
(iv)
authorised financial service providers under South African law;
|
|
| | | | |
(v)
financial institutions recognised as such under South African law;
|
|
| | | | |
(vi)
a wholly-owned subsidiary of any person or entity contemplated in (iii), (iv) or (v), acting as agent in the capacity of an authorised portfolio manager for a pension fund, or as manager for a collective investment scheme (in each case duly registered as such under South African law);
|
|
| | | | |
(vii)
any combination of the person in (i) to (vi); or
|
|
| | Section 96(1) (b) | | | the total contemplated acquisition cost of the securities, for any single addressee acting as principal is equal to or greater than ZAR1,000,000 or such higher amount as may be promulgated by notice in the Government Gazette of South Africa pursuant to section 96(2)(a) of the South African Companies Act. | |
340 Seven Springs Way, Suite 100
Brentwood, Tennessee 37027
(615) 296-3000
Attention: Investor Relations
Preferred stock
Debt securities
Offered by the Selling Stockholders
| | | |
Page
|
| |||
|
ABOUT THIS PROSPECTUS
|
| | | | ii | | |
| SUMMARY | | | | | 1 | | |
|
RISK FACTORS
|
| | | | 2 | | |
|
FORWARD-LOOKING STATEMENTS
|
| | | | 3 | | |
|
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | 5 | | |
|
INFORMATION INCORPORATED BY REFERENCE
|
| | | | 6 | | |
|
USE OF PROCEEDS
|
| | | | 7 | | |
|
GENERAL DESCRIPTION OF SECURITIES
|
| | | | 8 | | |
|
DESCRIPTION OF CAPITAL STOCK
|
| | | | 9 | | |
|
DESCRIPTION OF DEBT SECURITIES
|
| | | | 14 | | |
|
SELLING STOCKHOLDERS
|
| | | | 26 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 28 | | |
|
LEGAL MATTERS
|
| | | | 33 | | |
| EXPERTS | | | | | 33 | | |
340 Seven Springs Way, Suite 100
Brentwood, Tennessee 37027
(615) 296-3000
Attention: Investor Relations
| | | |
Shares of
Common Stock Beneficially Owned |
| |
Shares of
Common Stock That May be Sold Hereunder |
| |
Shares of Common Stock
Beneficially Owned After Sale of All Common Stock That May be Sold Hereunder(1) |
| |||||||||||||||||||||
|
Name of Selling Stockholder
|
| |
Shares
|
| |
Percentage
|
| |
Shares
|
| |
Percentage
|
| ||||||||||||||||||
|
EGI-AM(2)
|
| | | | 77,246,499 | | | | | | 54.0% | | | | | | 77,246,499 | | | | | | — | | | | | | — | | |
|
Pure Health(3)
|
| | | | 30,262,664 | | | | | | 21.1% | | | | | | 30,262,664 | | | | | | — | | | | | | — | | |
|
Ventas(4)
|
| | | | 9,342,501 | | | | | | 6.5% | | | | | | 9,342,501 | | | | | | — | | | | | | — | | |
|
David Vandewater(5)
|
| | | | 1,767,959 | | | | | | 1.2% | | | | | | 1,767,959 | | | | | | — | | | | | | — | | |
|
Stephen C. Petrovich(6)
|
| | | | 1,051,089 | | | | | | * | | | | | | 1,043,423 | | | | | | 7,666 | | | | | | * | | |
|
Neil Hemphill(7)
|
| | | | 790,596 | | | | | | * | | | | | | 790,596 | | | | | | — | | | | | | — | | |
| |
BofA Securities
|
| | Citigroup | | |
Leerink Partners
|
| |
Mizuho
|
|
| |
RBC Capital Markets
|
| |
Stephens Inc.
|
| |
Truist Securities
|
|
| | | | |
Capital One Securities
|
| | | |